Bisphosphonates for cardiovascular risk reduction: a systematic review and meta-analysis

G Kranenburg, JW Bartstra, M Weijmans, PA de Jong… - Atherosclerosis, 2016 - Elsevier
Background and aims Bisphosphonates might be effective in reducing cardiovascular
events due to their ability to reduce calcification in arterial walls. We aimed to investigate the …

Bone loss and vascular calcification: a bi-directional interplay?

C Vassalle, A Mazzone - Vascular pharmacology, 2016 - Elsevier
Vascular calcification (VC) represents a recognized adverse predictor for cardiovascular
morbidity and mortality. Previously considered passive and degenerative, VC is now …

[HTML][HTML] Decreased expression of Klotho in cardiac atria biopsy samples from patients at higher risk of atherosclerotic cardiovascular disease

G Corsetti, E Pasini, TM Scarabelli… - Journal of geriatric …, 2016 - ncbi.nlm.nih.gov
Background Klotho proteins (α-and β) are membrane-based circulating proteins that
regulate cell metabolism, as well as the lifespan modulating activity of Fibroblast Growth …

Where do we stand on vascular calcification?

KI Boström - Vascular pharmacology, 2016 - Elsevier
Vascular disease, such as atherosclerosis and diabetic vasculopathy, is frequently
complicated by vascular calcification. Previously believed to be an end-stage process of …

Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients

YT Lee, HY Ng, TTY Chiu, LC Li, SN Pei, WH Kuo… - Clinica Chimica …, 2016 - Elsevier
Background Abdominal aortic calcification (AAC) is commonly observed in chronic dialysis
patients and is associated with cardiovascular and all-cause mortality. We investigated the …

Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases

P Magni, C Macchi, CR Sirtori… - Clinical Chemistry and …, 2016 - degruyter.com
Clear evidence supports a role for circulating and locally-produced osteocalcin (OC) in the
pathophysiology of cardiovascular (CV) lesions and CV risk, also in combination with …

Serum sclerostin as an independent marker of peripheral arterial stiffness in renal transplantation recipients: a cross-sectional study

BG Hsu, HH Liou, CJ Lee, YC Chen, GJ Ho, MC Lee - Medicine, 2016 - journals.lww.com
Wnt/β-catenin signaling pathway is thought to be implicated in the development of arterial
stiffness and vascular calcification. As a Wnt signaling pathway inhibitor, it is interesting to …

Curcumin attenuates osteogenic differentiation and calcification of rat vascular smooth muscle cells

M Hou, Y Song, Z Li, C Luo, JS Ou, H Yu, J Yan… - Molecular and Cellular …, 2016 - Springer
Vascular calcification has been considered as a biological process resembling bone
formation involving osteogenic differentiation. It is a major risk factor for cardiovascular …

Proteomic biomarkers panel: new insights in chronic kidney disease

S Mihai, E Codrici, ID Popescu, AM Enciu… - Disease …, 2016 - Wiley Online Library
Chronic kidney disease, despite being a “silent epidemic” disease, represents one of the
main causes of mortality in general population, along with cardiovascular disease, which is …

Increased IL-37 concentrations in patients with arterial calcification

K Yu, X Min, Y Lin, Y Huang, S Huang, L Liu, Y Peng… - Clinica Chimica …, 2016 - Elsevier
Background Our previous study indicates that IL-37 plays a critical role in both
atherosclerosis and arterial calcification. However, whether IL-37 concentrations are …